- Home
- BCAX vs MCS Comparison
BCAX vs MCS Comparison
Compare BCAX & MCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAX
- MCS
- Stock Information
- Founded
- BCAX 2018
- MCS 1935
- Country
- BCAX United States
- MCS United States
- Employees
- BCAX N/A
- MCS N/A
- Industry
- BCAX
- MCS Movies/Entertainment
- Sector
- BCAX
- MCS Consumer Discretionary
- Exchange
- BCAX NYSE
- MCS Nasdaq
- Market Cap
- BCAX 670.9M
- MCS 537.6M
- IPO Year
- BCAX 2024
- MCS N/A
- Fundamental
- Price
- BCAX $12.97
- MCS $16.93
- Analyst Decision
- BCAX Buy
- MCS Strong Buy
- Analyst Count
- BCAX 7
- MCS 4
- Target Price
- BCAX $29.67
- MCS $23.75
- AVG Volume (30 Days)
- BCAX 586.0K
- MCS 157.6K
- Earning Date
- BCAX 05-20-2025
- MCS 05-06-2025
- Dividend Yield
- BCAX N/A
- MCS 1.66%
- EPS Growth
- BCAX N/A
- MCS N/A
- EPS
- BCAX N/A
- MCS N/A
- Revenue
- BCAX N/A
- MCS $704,626,000.00
- Revenue This Year
- BCAX N/A
- MCS $11.30
- Revenue Next Year
- BCAX N/A
- MCS $5.20
- P/E Ratio
- BCAX N/A
- MCS N/A
- Revenue Growth
- BCAX N/A
- MCS 3.81
- 52 Week Low
- BCAX $8.91
- MCS $9.56
- 52 Week High
- BCAX $28.09
- MCS $23.16
- Technical
- Relative Strength Index (RSI)
- BCAX N/A
- MCS 54.66
- Support Level
- BCAX N/A
- MCS $15.42
- Resistance Level
- BCAX N/A
- MCS $16.98
- Average True Range (ATR)
- BCAX 0.00
- MCS 0.44
- MACD
- BCAX 0.00
- MCS 0.11
- Stochastic Oscillator
- BCAX 0.00
- MCS 89.88
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
About MCS Marcus Corporation (The)
Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.